银丹心脑通软胶囊联合3种化学药物治疗冠心病心绞痛的疗效观察  

Efficacy Observation of Yindanxinnaotong Soft Capsules Combined with 3 Chemicals for Coronary Disease Angina Pectoris

作　　者：杨文波[1] 

机构地区：[1]延边大学附属医院药剂科,延吉市133000

出　　处：《中国药房》2010年第4期370-371,共2页China Pharmacy

摘　　要：目的:观察银丹心脑通软胶囊联合3种化学药物治疗冠心病心绞痛的临床疗效。方法:选择符合诊断标准的病例共91例,随机分为2组:对照组44例,给予单硝酸异山梨酯缓释片10～20mg,bid;富马酸比索洛尔片5～10mg,qd;苯磺酸氨氯地平片5mg,qd,常规治疗;治疗组47例,在常规治疗基础上口服银丹心脑通软胶囊,每次2～4粒,tid,30d为一疗程。结果:治疗组心绞痛与心电图改善情况分别为80.85%和74.47%,对照组为61.36%和56.82%,2组比较差异均有显著性(P<0.05)。结论:银丹心脑通软胶囊联合单硝酸异山梨酯缓释片、富马酸比索洛尔片、苯磺酸氨氯地平片治疗冠心病心绞痛提高了疗效。OBJECTIVE： To observe the therapeutic effect of Yindanxinnaotong Soft Capsules combined with three chemicals for coronary disease angina pectoris. METHODS： 91 cases which were up to the diagnosis standard were randomly divided into control group （n=44） and treatment group （n=47）. Control groups were treated with the routine isosorbide 5-mononitrate sustained release tablets （10-20 mg, bid）, bisoprolol fumarate tablets （5-10 mg, qd）; amlodipine besylate tablets （5 mg, qd）. Treatment group were additionally treated with 2 to 4 Yindanxinnaotong Soft Capsules, tid, p.o, with treating course of 30 days. RESULTS： The total efficacy rate of angina pectoris and the electrocardiogram were 80.85% and 74.47% for treatment group while 61.36% and 56.82% for control group. There was significant difference between two groups （P〈0.05）. CONCLUSION： The therapeutic effect is improved by using Yindanxinnaotong Soft Capsules combined with isesorbide 5-mononitrate sustained release tablets, bisoprolol fumarate tablets, amlodipine besylate tablets for coronary disease angina pectoris.

关 键 词：冠心病 心绞痛 银丹心脑通软胶囊 

分 类 号：R972.3[医药卫生—药品]